BLOG

Lazertinib Intermediate Supplier | CAS NO:  26033-20-5 Following the European Medicines Agency (EMA) marketing authorization of Lazcluze™ (Lazertinib) in combination with amivantamab for first-line treatment of adult patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) across the European Union, pharmaceutical manufacturers, CDMOs, and generic developers in Germany, the UnitedContinue Reading

High-Purity Orforglipron Intermediates: Direct Manufacturing Partner for UK & Europe The authorization of Orforglipron (Foundayo™) by the UK Medicines and Healthcare products Regulatory Agency (MHRA) in August 2026 marked a historic turning point in the European pharmaceutical market. As the world’s first oral, non-peptide small-molecule GLP-1 receptor agonist authorized forContinue Reading

Lazertinib & Orforglipron Intermediates: Manufacturer & Supplier The global pharmaceutical landscape in 2026 is witnessing surging commercial demand for advanced small-molecule therapeutics. In the European Union and United Kingdom, two high-impact active pharmaceutical ingredients (APIs) dominate procurement and R&D pipelines: Lazertinib (Lazcluze™)—the 3rd-generation EGFR tyrosine kinase inhibitor approved by theContinue Reading

The pharmaceutical and chemical industries rely on high-performance coupling reagents for peptide synthesis, drug development, and advanced organic chemistry. One of the most widely used reagents in these applications is EDC HCl, a highly effective carbodiimide-based coupling agent used in pharmaceutical research and chemical synthesis. With increasing demand for peptide-basedContinue Reading

EDC HCL Properties form crystalline Quality Level 200 reaction suitability reagent type: cross-linking reagent reaction type: Peptide Synthesis mp 110-115 °C (lit.) solubility H2O: ≤100 mg/mL storage temp. −20°C SMILES string Cl.CCN=C=NCCCN(C)C InChI 1S/C8H17N3.ClH/c1-4-9-8-10-6-5-7-11(2)3;/h4-7H2,1-3H3;1H InChI key FPQQSJJWHUJYPU-UHFFFAOYSA-N   EDC HCL Introduction: N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride, commonly known as EDC or EDAC, isContinue Reading